|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 75.70 EUR | -0.46% |
|
+5.14% | -3.01% |
| 05-11 | Bio-K+ Advances Research on Gut Health and Autism Spectrum Disorder with Clinical Study Findings | CI |
| 05-01 | Kerry Group plc, Q1 2026 Interim Management Statement Call, Apr 30, 2026 |
EPS & Dividend: Kerry Group plc
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | 0.952 | 1.048 | 1.154 | 1.271 | 1.4 | 1.527 | 1.684 | 1.852 |
| Rate of return | 0.84% | 1.24% | 1.47% | 1.36% | 1.79% | 2.01% | 2.21% | 2.43% |
| EPS 2 | 4.296 | 3.413 | 4.097 | 4.238 | 3.993 | 4.566 | 5.101 | 5.703 |
| Distribution rate | 22.2% | 30.7% | 28.2% | 30% | 35.1% | 33.5% | 33% | 32.5% |
| Reference price 2 | 113.25 | 84.24 | 78.66 | 93.25 | 78.00 | 76.05 | 76.05 | 76.05 |
| Nbr of stocks (in thousands) | 176,845 | 176,985 | 175,788 | 169,284 | 161,097 | 159,281 | - | - |
| Announcement Date | 16/02/22 | 16/02/23 | 15/02/24 | 18/02/25 | 17/02/26 | - | - | - |
1EUR in Million2EUR
Estimates
Past dividends: Kerry Group plc
| 09/04/2026 | Ex-dividend date - 0.98 EUR | 05:00 |
| 09/10/2025 | Ex-dividend date - 0.42 EUR | 05:00 |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | 2.01% | 2.21% | 16.66x | 1.97x | 2.08x | |
| 3.95% | 4.02% | 19.77x | 5.76x | 2.87x | |
| 3.26% | 3.5% | 21.75x | 3.2x | 2.54x | |
| 3.54% | 3.77% | 17.44x | 2.31x | 1.78x | |
| - | - | - | - | - | |
| 2.63% | 2.72% | 17.35x | 1.7x | 0.53x | |
| 3.19% | 3.32% | 22.53x | 7.38x | 3.33x | |
| 1.1% | 1.27% | 69.5x | 44.46x | 10.37x | |
| 6.63% | 6.66% | 11.57x | 0.68x | 1.89x | |
| 0.94% | 0.99% | 37.95x | 6.91x | 3.29x | |
| Average | 3.03% | 3.16% | 26.06x | 8.26x | 3.19x | |
| Weighted average by Cap. | 3.46% | 3.58% | 22.89x | 6.60x | 2.94x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition